Tai Chi Exercise in Patients With COPD

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT01027338
First received: December 4, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

This is a pilot randomized controlled trial of feasibililty and prelimnary effects of a 12 week tai chi intervention vs. usual care in patients with chronic obstructive pulmonary disease


Condition Intervention Phase
COPD
Other: Tai chi exercise
Phase 1

Study Type: Interventional
Official Title: Tai Chi Exercise in Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:


Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Primary Outcome Measures:
  • study feasibility [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • quality of life [ Designated as safety issue: No ]
  • exercise capacity [ Designated as safety issue: No ]

Arms Assigned Interventions
Experimental: Tai Chi Exercise Other: Tai chi exercise
No Intervention: Usual Care

  Eligibility

Ages Eligible for Study:   45 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • physician diagnosis of COPD
  • FEV1<65% of predicted and FEV1/FVC<70% of predicted
  • ≥45 years old

Exclusion Criteria:

  • COPD exacerbation requiring ER visit or hospitalization within past month
  • planned major pulmonary intervention in coming 3 months
  • severe peripheral vascular disease/claudication or other physical condition precluding walk test
  • inability to perform bicycle ergometry
  • severe cognitive dysfunction (MMSE ≤ 24)
  • inability to speak English
  • current participation in a pulmonary rehabilitation or regular practice of tai chi
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01027338

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Investigators
Principal Investigator: Gloria Y Yeh, MD, MPH Beth Israel Deaconess Medical Center
  More Information

No publications provided

Responsible Party: Russell Phillips, MD, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01027338     History of Changes
Other Study ID Numbers: K24AT000589
Study First Received: December 4, 2009
Last Updated: December 4, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 21, 2014